Administration is responsible for providing expert administrative support to Cancer Center leadership and services to members in order to foster highly interactive scientific environment that encourages interdisciplinary cancer research across programs, departments and the cancer continuum, and fosters new interactions, collaborations, and engagement. Led by the Associate Director for Administration and Education, the administrative team has been instrumental in developing new Research Programs and Shared Resources; coordinating and managing planning and evaluation activities to assure continued excellence in meeting USC Norris and member needs; advocating, prioritizing and managing resources for the benefit of USC Norris and its members; and ensuring that our researchers have the infrastructure, systems, and assistance needed to conduct important research in an interdisciplinary collaborative manner. Senior Leadership is comprised of the Director and five Associate Directors (basic research, adult oncology, cancer prevention and control, pediatric oncology, and administration and education). Senior Leaders set the strategic research directions of USC Norris through an integrated strategic planning, evaluation and process improvement approach. This highly effective process includes Program Leaders, members, Shared Resource Directors, and the External Advisory Board. This complements the role of Associate Directors who share direct responsibility for scientific oversight of Research Programs and Shared Resources. The shared oversight model encourages a high degree of interaction and joint development of interdisciplinary and collaborative research. As an example, the Senior Leaders worked together to define and clarify the goals for the new Program in Translational and Clinical Sciences. Together, they also ensure that the educational and training activities of the Center are appropriate and aligned with our scientific goals and that the cancer problems of the catchment area are addressed through both programmatic research and outreach activities. Oversight of clinical protocol development and resources to support innovative clinical research is provided by the Associate Director for Adult Oncology. The Associate Director for Pediatric Oncology helps assure the integration of pediatric populations and facilitates translation of research from basic science laboratories. The Associate Director for Administration and Education provides strategic oversight of the business and financial operations of USC Norris. Her administrative team provides the administrative, fiscal, information technology, facilities management, communication, and planning support required to effectively and efficiently enable Senior Leaders to realize the vision of USC Norris and meet the needs of investigators conducting leading- edge cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-45
Application #
9838154
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Schaal, Justin B; Maretzky, Thorsten; Tran, Dat Q et al. (2018) Macrocyclic ?-defensins suppress tumor necrosis factor-? (TNF-?) shedding by inhibition of TNF-?-converting enzyme. J Biol Chem 293:2725-2734
Iriondo, Oihana; Liu, Yarong; Lee, Grace et al. (2018) TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis. Nat Commun 9:1994
Robison, Nathan J; Yeo, Kee Kiat; Berliner, Adrian P et al. (2018) Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. J Neurooncol 138:199-207
Naseem, Madiha; Barzi, Afsaneh; Brezden-Masley, Christine et al. (2018) Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev 66:15-22
Sebio, A; Stintzing, S; Heinemann, V et al. (2018) A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials. Pharmacogenomics J 18:43-48
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472
Peddi, Santosh; Pan, Xiaoli; MacKay, John Andrew (2018) Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis. Front Pharmacol 9:1184
Guo, Hao; Lee, Changrim; Shah, Mihir et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. J Control Release 292:183-195
Zhao, Yi; Wu, Kaijin; Wu, Yongfeng et al. (2018) Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists. Curr Mol Pharmacol 11:113-121
Kahn, Michael (2018) Wnt Signaling in Stem Cells and Cancer Stem Cells: A Tale of Two Coactivators. Prog Mol Biol Transl Sci 153:209-244

Showing the most recent 10 out of 842 publications